Comorbidities in chronic obstructive pulmonary disease
- PMID: 18453370
- PMCID: PMC2645334
- DOI: 10.1513/pats.200709-148ET
Comorbidities in chronic obstructive pulmonary disease
Abstract
Comorbidities such as cardiac disease, diabetes mellitus, hypertension, osteoporosis, and psychological disorders are commonly reported in patients with chronic obstructive pulmonary disease (COPD) but with great variability in reported prevalence. Tobacco smoking is a risk factor for many of these comorbidities as well as for COPD, making it difficult to draw conclusions about the relationship between COPD and these comorbidities. However, recent large epidemiologic studies have confirmed the independent detrimental effects of these comorbidities on patients with COPD. On the other hand, many of these comorbidities are now considered to be part of the commonly prevalent nonpulmonary sequelae of COPD that are relevant not only to the understanding of the real burden of COPD but also to the development of effective management strategies.
References
-
- van Manen JG, Bindels PJ, IJzermans CJ., van der Zee JS, Bottema BJ, Schade E. Prevalence of comorbidity in patients with a chronic airway obstruction and controls over the age of 40. J Clin Epidemiol 2001;54:287–293. - PubMed
-
- Mapel DW, Hurley JS, Frost FJ, Petersen HV, Picchi MA, Coultas DB. Health care utilization in chronic obstructive pulmonary disease: a case-control study in a health maintenance organization. Arch Intern Med 2000;160:2653–2658. - PubMed
-
- Patil SP, Krishnan JA, Lechtzin N, Diette GB. In-hospital mortality following acute exacerbations of chronic obstructive pulmonary disease. Arch Intern Med 2003;163:1180–1186. - PubMed
-
- Almagro P, Calbo E, Ochoa de Echaguen A, Barreiro B, Quintana S, Heredia JL, Garau J. Mortality after hospitalization for COPD. Chest 2002;121:1441–1448. - PubMed
-
- Antonelli Incalzi R, Fuso L, De Rosa M, Forastiere F, Rapiti E, Nardecchia B, Pistelli R. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997;10:2794–2800. - PubMed
Publication types
MeSH terms
Grants and funding
- N01HR76113/HR/NHLBI NIH HHS/United States
- N01HR76107/HR/NHLBI NIH HHS/United States
- N01HR76102/HR/NHLBI NIH HHS/United States
- N01HR76104/HR/NHLBI NIH HHS/United States
- N01HR76118/HR/NHLBI NIH HHS/United States
- N01HR76115/HR/NHLBI NIH HHS/United States
- N01HR76105/HR/NHLBI NIH HHS/United States
- N01HR76111/HR/NHLBI NIH HHS/United States
- N01HR76114/HR/NHLBI NIH HHS/United States
- N01HR76103/HR/NHLBI NIH HHS/United States
- N01HR76110/HR/NHLBI NIH HHS/United States
- N01HR76119/HR/NHLBI NIH HHS/United States
- N01HR76108/HR/NHLBI NIH HHS/United States
- N01HR76106/HR/NHLBI NIH HHS/United States
- N01HR76109/HR/NHLBI NIH HHS/United States
- N01HR76116/HR/NHLBI NIH HHS/United States
- N01HR76112/HR/NHLBI NIH HHS/United States
- N01HR76101/HR/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical